Pharmaceutical Technology

AUGUST 16, 2024

Genomic medicines offer new techniques for treating conditions once thought to be intractable - a world of opportunity awaits.

Genomics 246

Genomics Genome Medicine 246

Pharmaceutical Technology

JULY 30, 2024

GSK has announced a strategic collaboration with Flagship Pioneering for the discovery and development of medicines and vaccines.

Medicine 244

Medicine Vaccination Vaccine Development 244

Drug Patent Watch

DECEMBER 9, 2024

This intersection is where pharmacognosy meets drug patents, creating a unique landscape that shapes the future of medicine. Let’s embark on a journey to uncover the secrets of nature’s medicine cabinet and the legal frameworks that protect these discoveries.

Medicine 97

Medicine Drugs Production Development 97

Bio Pharma Dive

JUNE 27, 2024

A growing cohort of biotechs, from Biohaven to Neurocrine to Jazz, hope research on ion channels will bring them new drugs and big business — much like it has done for Vertex.

Medicine 345

Medicine Drugs Research 345

Bio Pharma Dive

APRIL 25, 2023

Biogen’s drug failed the key study meant to show it can slow the nerve-destroying disease, but the drug’s effect on a protein of interest led the FDA to conditionally clear it for market.

FDA Approval 352

FDA Approval Medicine Protein Marketing 352

AuroBlog - Aurous Healthcare Clinical Trials blog

SEPTEMBER 30, 2024

Researchers see a greater need for new generation therapeutics to propel precision medicine. The development of innovative therapeutic approaches in healthcare encompass a variety of fields, including gene therapy, personalized medicine, immunotherapy, and advanced biologics.

Medicine 189

Medicine Research Gene Therapy Genetics 189

Bio Pharma Dive

JULY 31, 2024

Launched last September, the company is working on a treatment for alpha-1 antitrypsin deficiency, which it said could enter the clinic in 2025.

RNA 298

RNA Medicine 298

Bio Pharma Dive

DECEMBER 10, 2023

A new sickle cell disease therapy developed by CRISPR Therapeutics and Vertex Pharmaceuticals is now approved in the U.S. This is the story of how it came to be.

Medicine 357

Medicine Development 357

Bio Pharma Dive

OCTOBER 20, 2022

The gene editing startup is one of less than two dozen biotech companies to debut on Wall Street this year, as the pace of IPOs remains far off last year’s trajectory.

Gene Editing 356

Gene Editing Medicine Gene 356

Bio Pharma Dive

JULY 15, 2024

Updated results show the biotech's RAS inhibitor shrank pancreatic tumors in 20% to 25% of study participants, but with high rates of side effects like rash and nausea.

Medicine 325

Medicine Trials Drugs 325

Pharmaceutical Technology

FEBRUARY 11, 2025

The World Health Organization and St Jude Children's Research Hospital have kicked off a programme to distribute cancer medicines to LMICs.

Medicine 200

Medicine Research 200

Bio Pharma Dive

JANUARY 16, 2024

The agency’s decision to expand use of Casgey, which won a landmark OK for sickle cell disease in December, comes more than two months ahead of schedule.

Medicine 317

Medicine 317

Pharmaceutical Technology

MARCH 14, 2024

The funds will be used to expand Zephyr AI's headcount and enhance datasets.

Medicine 312

Medicine 312

Bio Pharma Dive

NOVEMBER 16, 2023

Clearance of Vertex Pharmaceuticals and CRISPR Therapeutics' Casgevy in the U.K. comes ahead of expected regulatory decisions in the U.S. and Europe.

Medicine 317

Medicine 317

Bio Pharma Dive

JANUARY 22, 2024

Trodelvy didn’t outperform chemotherapy in a large study of people with a common lung tumor, a setback that sent company shares down by double digits.

Medicine 305

Medicine 305

Bio Pharma Dive

SEPTEMBER 19, 2024

GC Therapeutics claims it can create off-the-shelf therapies from induced pluripotent stem cells faster than by current methods with a simpler process.

Medicine 276

Medicine Development 276

Pharmaceutical Technology

FEBRUARY 13, 2024

The MHRA kicks off phase two of the Yellow Card biobank to explore the genetic link to side effects of direct oral anticoagulants.

Biobanking 277

Biobanking Medicine Genetics 277

Bio Pharma Dive

OCTOBER 9, 2024

The company, which is building a database of biological interactions found in nature, revealed $60 million in funding and a collaboration with David Liu’s lab.

Genetics 290

Genetics Medicine 290

Bio Pharma Dive

MAY 19, 2023

The biotech, best known for its vaccine research, said its clinical trial is the first to report results of a messenger RNA therapeutic designed for intracellular protein replacement.

RNA 305

RNA Medicine Clinical Trials Clinical Trials 305

Pharmaceutical Technology

JULY 8, 2024

GSK and MMV have announced the launch of tafenoquine to prevent the relapse of P. vivax malaria in Brazil and Thailand.

Medicine 256

Medicine 256

Pharmaceutical Technology

FEBRUARY 21, 2025

Incyte and Genesis have entered a strategic partnership for the research, discovery and development of new small-molecule medicines.

Medicine 147

Medicine Development Research 147

Pharmaceutical Technology

FEBRUARY 28, 2024

Pelage Pharmaceuticals has secured $16.75m in a Series A financing round to further the development of PP405 for hair loss.

Development 261

Development Medicine 261

AuroBlog - Aurous Healthcare Clinical Trials blog

JULY 10, 2024

By focusing on clinical excellence, comprehensive education, and cutting-edge research, the Arya Vaidya Pharmacy Research Foundation (AVPRF) based in Coimbatore is ensuring that ayurvedic practices are validated, credible, and relevant for future generations.

Medicine 233

Medicine Pharmacy Research Clinical Trials 233

Bio Pharma Dive

JANUARY 12, 2025

The biotech plans to use the funding to advance clinical testing of an epigenetic silencing therapy it hopes could treat chronic hepatitis B infections.

Medicine 214

Medicine Research 214

Pharmaceutical Technology

FEBRUARY 8, 2024

Despite several ground-breaking developments, pharmaceutical and biotech companies are often reluctant to invest in cell and gene therapy.

Gene Therapy 246

Gene Therapy Gene Medicine Development 246

Velocity Clinical Research

MARCH 19, 2025

Full article: [link] The post Charles Eger, MD, Authors New Article in Nature Medicine appeared first on Velocity Clinical Research. Early results from the Phase 1/2 trial show that the vaccine is well-tolerated and induces strong immune responses, potentially paving the way for a more convenient approach to respiratory virus prevention.

Medicine 52

Medicine Immune Response Vaccination Vaccine 52

Pharmaceutical Technology

JANUARY 27, 2025

With continued investment and growing buzz from the industry, the AI hype is expected to extend through 2025 and beyond.

Medicine 179

Medicine 179

Medical Xpress

MARCH 7, 2025

Published in npj Regenerative Medicine, the study reveals a novel approach to promoting cardiomyocyte proliferation. DeBakey Department of Surgery at Baylor College of Medicine, the QIMR Berghofer Medical Research Institute in Brisbane, Australia, and collaborating institutions. The researchers are from the Michael E.

Medicine 129

Medicine Research 129

Rethinking Clinical Trials

DECEMBER 11, 2024

Gbenga Ogedegbe In this Friday’s PCT Grand Rounds, Gbenga Ogedegbe of the NYU Grossman School of Medicine will present “Home Blood Pressure Telemonitoring and Nurse Case Management in Black and Hispanic Patients With Stroke: A Randomized Clinical Trial.” Join the online meeting.

Clinical Trials 146

Clinical Trials Clinical Trials Nurses Medicine 146

Bio Pharma Dive

NOVEMBER 5, 2024

The death, which investigators linked to a preparatory chemo treatment rather than Beam's medicine, highlights the risks of using decades-old transplant drugs alongside cutting-edge CRISPR medicines.

Medicine 305

Medicine Drugs 305

Rethinking Clinical Trials

NOVEMBER 13, 2024

Delgado is an associate professor of emergency medicine and epidemiology at the University of Pennsylvania and the director of the Penn Medicine Nudge Unit, which “designs and implements scalable nudges to improve medical decision-making and patient outcomes.” ” Join the online meeting.

Trials 170

Trials Clinical Trials Clinical Trials Medicine 170

Bio Pharma Dive

OCTOBER 22, 2024

Early study data from Wave Life Sciences suggests how editing RNA may yield viable medicines. Large and small drugmakers say such results are just the start.

RNA 354

RNA Life Science Medicine 354

Rethinking Clinical Trials

FEBRUARY 12, 2025

Volandes is a professor of medicine at the Geisel School of Medicine at Dartmouth and the vice chair for research in the Department of Medicine at Dartmouth Health. Tulsky is a professor of medicine at Harvard Medical School and the Poorvu Jaffe Chair of Supportive Oncology at the Dana-Farber Cancer Institute.

Trials 146

Trials Medicine Clinical Trials Clinical Trials 146

Bio Pharma Dive

APRIL 8, 2024

But many development hurdles still stand in the way of new medicines for the brain. Recent biotech company acquisitions have put emerging schizophrenia treatments in focus.

Medicine 344

Medicine Drugs Development 344

Bio Pharma Dive

SEPTEMBER 4, 2024

Over the past 10 years, PD1-blocking medicines have transformed cancer care. But the steady expansion of their use has slowed and, despite much trying, pharmaceutical companies have largely failed to top the drugs’ successes.

Drugs 351

Drugs Medicine 351

Bio Pharma Dive

MARCH 27, 2023

The medicine, a personalized stem cell treatment, will be reviewed by an FDA advisory committee sometime in the future, the company said.

Medicine 363

Medicine Drugs 363